Role of self-monitoring of blood glucose in glycemic control.
OBJECTIVE
To examine the role of self-monitoring of blood glucose (SMBG) in the management of diabetes mellitus.


METHODS
Current trends and published evidence are reviewed.


RESULTS
Despite the widespread evidence that lowering glycemic levels reduces the risks of complications in patients with diabetes, little improvement in glycemic control has been noted among patients in the United States and Europe in recent years. Although SMBG has been widely used, considerable controversy surrounds its role in achieving glycemic control. The high cost of test strips has made considerations regarding appropriate recommendations for SMBG a priority, especially in light of the current climate of health-care cost-containment. Existing clinical recommendations lack specific guidance to patients and clinicians regarding SMBG practice intensity and frequency, particularly for those patients not treated with insulin. Previous studies of the association between SMBG and glycemic control often found weak and conflicting results.


CONCLUSIONS
A reexamination of the role of SMBG is needed, with special attention to the unique needs of patients using different diabetes treatments, within special clinical subpopulations, and during initiation of SMBG versus its ongoing use. Further understanding of the intensity and frequency of SMBG needed to reflect the variability in glycemic patterns would facilitate more specific guideline development. Educational programs that focus on teaching patients the recommended SMBG practice, specific glycemic targets, and appropriate responses to various blood glucose readings would be beneficial. Continuing medical education programs for health-care providers should suggest ways to analyze patient SMBG records to tailor medication regimens. For transfer or communication of SMBG reports to the clinical staff, a standardized format that extracts key data elements and allows quick review by health-care providers would be useful. Because the practice of SMBG is expensive, the cost-effectiveness of SMBG needs to be carefully assessed.
Karter
Andrew J
AJ
Division of Research, Kaiser Permanente, Oakland, California, USA.
D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring / Q000706:statistics & numerical data; D003362:Cost-Benefit Analysis; D003920:Diabetes Mellitus / Q000097:blood* / Q000188:drug therapy; D004502:Education, Medical, Continuing; D017048:Health Care Costs; D006801:Humans; D010353:Patient Education as Topic; D016032:Randomized Controlled Trials as Topic; D011934:Reagent Strips / Q000191:economics
D001786:Blood Glucose; D011934:Reagent Strips